General American Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.18M | Sell |
9,876
-5,000
| -34% | -$2.63M | 0.33% | 54 |
|
|
2025
Q1 | $9.43M | Hold |
14,876
| – | – | 0.69% | 42 |
|
|
2024
Q4 | $10.6M | Buy |
14,876
+3,000
| +25% | +$2.14M | 0.74% | 41 |
|
|
2024
Q3 | $12.5M | Sell |
11,876
-2,700
| -19% | -$2.84M | 0.86% | 41 |
|
|
2024
Q2 | $15.3M | Hold |
14,576
| – | – | 1.07% | 28 |
|
|
2024
Q1 | $14M | Sell |
14,576
-2,000
| -12% | -$1.92M | 1% | 28 |
|
|
2023
Q4 | $14.6M | Hold |
16,576
| – | – | 1.15% | 23 |
|
|
2023
Q3 | $13.6M | Hold |
16,576
| – | – | 1.22% | 24 |
|
|
2023
Q2 | $11.9M | Buy |
16,576
+1,500
| +10% | +$1.08M | 1.04% | 33 |
|
|
2023
Q1 | $12.4M | Hold |
15,076
| – | – | 1.17% | 29 |
|
|
2022
Q4 | $10.9M | Sell |
15,076
-3,000
| -17% | -$2.16M | 1.06% | 34 |
|
|
2022
Q3 | $12.5M | Sell |
18,076
-3,000
| -14% | -$2.07M | 1.3% | 30 |
|
|
2022
Q2 | $12.5M | Sell |
21,076
-2,000
| -9% | -$1.18M | 1.25% | 31 |
|
|
2022
Q1 | $16.1M | Sell |
23,076
-7,000
| -23% | -$4.89M | 1.32% | 28 |
|
|
2021
Q4 | $19M | Buy |
30,076
+14,075
| +88% | +$8.89M | 1.49% | 22 |
|
|
2021
Q3 | $9.68M | Buy |
16,001
+3,000
| +23% | +$1.82M | 0.82% | 43 |
|
|
2021
Q2 | $7.26M | Buy |
13,001
+1,500
| +13% | +$838K | 0.61% | 49 |
|
|
2021
Q1 | $5.44M | Buy |
+11,501
| New | +$5.44M | 0.51% | 53 |
|